Today CME Group (CME) Hits New Five Year High

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Trade-Ideas LLC identified CME Group ( CME) as a new five year high candidate. In addition to specific proprietary factors, Trade-Ideas identified CME Group as such a stock due to the following factors:

  • CME has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $125.1 million.
  • CME has traded 1.5 million shares today.
  • CME is trading at a new five year high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in CME with the Ticky from Trade-Ideas. See the FREE profile for CME NOW at Trade-Ideas

More details on CME:

CME Group Inc. operates the CME, CBOT, NYMEX COMEX, and KCBT futures exchanges worldwide. It operates CBOT exchange, a marketplace for trading agricultural and the U.S. The stock currently has a dividend yield of 2.3%. CME has a PE ratio of 27.6. Currently there are 7 analysts that rate CME Group a buy, no analysts rate it a sell, and 7 rate it a hold.

The average volume for CME Group has been 1.6 million shares per day over the past 30 days. CME Group has a market cap of $26.4 billion and is part of the financial sector and financial services industry. The stock has a beta of 1.09 and a short float of 2.3% with 4.12 days to cover. Shares are up 55.2% year to date as of the close of trading on Thursday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

TheStreetRatings.com Analysis:

TheStreet Quant Ratings rates CME Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, increase in net income, reasonable valuation levels and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

Highlights from the ratings report include:
  • Since the same quarter one year prior, revenues slightly increased by 4.4%. This growth in revenue appears to have trickled down to the company's bottom line, improving the earnings per share.
  • Compared to where it was trading one year ago, CME is up 47.19% to its most recent closing price of 78.84. Looking ahead, although the push and pull of a bull or bear market could certainly alter the outcome, our view is that this stock's positive fundamentals give it good potential for further appreciation.
  • The net income increased by 8.6% when compared to the same quarter one year prior, going from $218.00 million to $236.70 million.
  • The gross profit margin for CME GROUP INC is rather high; currently it is at 65.14%. Regardless of CME's high profit margin, it has managed to decrease from the same period last year.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Trade Tussle Sinks Stocks, Oil Slides, Micron, Daimler - 5 Things You Must Know

Trade Tussle Sinks Stocks, Oil Slides, Micron, Daimler - 5 Things You Must Know

Bank of England Holds Rates Steady, But Vote Shift Signals Hawkish Tone

Bank of England Holds Rates Steady, But Vote Shift Signals Hawkish Tone

Futures Fall on Further Trade Rhetoric from China and 4 Other Stories to Watch

Futures Fall on Further Trade Rhetoric from China and 4 Other Stories to Watch

5 Biggest U.S. Tech Stocks Test $4 Trillion Valuation Amid Bullish Nasdaq Run

5 Biggest U.S. Tech Stocks Test $4 Trillion Valuation Amid Bullish Nasdaq Run

Trade War Fear Creeps Back Into Markets on Thursday

Trade War Fear Creeps Back Into Markets on Thursday